• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

收治于一家三级医院的 COVID-19 成年患者以及与严重程度相关的危险因素:一项回顾性队列研究。

Adult patients admitted to a tertiary hospital for COVID-19 and risk factors associated with severity: a retrospective cohort study.

机构信息

Grupo Hospitalar Conceição, Hospital Nossa Senhora da Conceição, Unidade de Terapia Intensiva Adulto, Porto Alegre, Rio Grande do Sul, Brazil.

Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.

出版信息

Rev Inst Med Trop Sao Paulo. 2022 Feb 25;64:e20. doi: 10.1590/S1678-9946202264020. eCollection 2022.

DOI:10.1590/S1678-9946202264020
PMID:35239864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8901117/
Abstract

COVID-19 is a disease whose knowledge is still under construction, high transmissibility, with no consensual treatment available to everyone. Therefore, the identification of patients at higher risk of evolving to the critical form of the disease is fundamental. The study aimed to determine risk factors associated with the severity of COVID-19 in adults patients. This is an observational, retrospective study from a cohort of adult patients with COVID-19 admitted to a public hospital from March to August 2020, whose medical records were evaluated. For the association of possible severity predictors, a Poisson regression was used. The primary outcome was the critical form of the disease (need for admission to the Intensive Care Unit and/or invasive mechanical ventilation). We included 565 patients: mostly men; 55.5% of those who progressed to the critical form of the disease were over sixty years old. Hypertension, diabetes mellitus and obesity were the most frequent comorbidities. There were 39.8% of patients who progressed to the critical form of the disease. The hospital mortality rate was 22.1%, and that of critical patients was 46.7%. The independent factors associated with the severity of the disease were obesity [RR = 1.33 (95% CI 1.07 to 1.66; p = 0.011)], SpO2/FiO2 ratio ≤ 315 [RR = 2.20 (95% CI 1.79 to 2.71; p = 0.000)], C-reactive protein > 100 mg/L [RR = 1.65 (95% CI 1.33 to 2.06; p = 0.000)], and lymphocytes < 1,000/µL [RR = 1.44 (95% CI 1.18 to 1.75; p = 0.000)]. Advanced age and comorbidities were dependent factors strongly associated with the critical form of the disease.

摘要

新型冠状病毒肺炎(COVID-19)是一种知识仍在不断完善的疾病,具有高度传染性,目前尚无针对所有人的共识性治疗方法。因此,确定哪些患者有更高的风险发展为疾病的危急形式至关重要。本研究旨在确定与成人 COVID-19 患者病情严重程度相关的危险因素。这是一项针对 2020 年 3 月至 8 月间在一家公立医院住院的成年 COVID-19 患者队列的观察性、回顾性研究,对其病历进行了评估。为了对可能的严重程度预测因素进行关联分析,我们使用了泊松回归。主要结局是疾病的危急形式(需要入住重症监护病房和/或接受有创机械通气)。我们共纳入 565 例患者:大多数为男性;55.5%发展为危急形式的患者年龄超过 60 岁。高血压、糖尿病和肥胖是最常见的合并症。有 39.8%的患者发展为危急形式。医院死亡率为 22.1%,危急患者的死亡率为 46.7%。与疾病严重程度相关的独立因素包括肥胖[RR=1.33(95%CI 1.07 至 1.66;p=0.011)]、SpO2/FiO2 比值≤315[RR=2.20(95%CI 1.79 至 2.71;p=0.000)]、C 反应蛋白>100mg/L[RR=1.65(95%CI 1.33 至 2.06;p=0.000)]和淋巴细胞<1,000/µL[RR=1.44(95%CI 1.18 至 1.75;p=0.000)]。高龄和合并症是与疾病危急形式密切相关的依赖因素。

相似文献

1
Adult patients admitted to a tertiary hospital for COVID-19 and risk factors associated with severity: a retrospective cohort study.收治于一家三级医院的 COVID-19 成年患者以及与严重程度相关的危险因素:一项回顾性队列研究。
Rev Inst Med Trop Sao Paulo. 2022 Feb 25;64:e20. doi: 10.1590/S1678-9946202264020. eCollection 2022.
2
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
3
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.与 SARS-CoV-2 谱系 B.1.1.7 相关的在英国的死亡率和重症监护病房入院率:一项观察性队列研究。
Lancet Infect Dis. 2021 Nov;21(11):1518-1528. doi: 10.1016/S1473-3099(21)00318-2. Epub 2021 Jun 23.
4
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.加拿大疫情第一阶段住院和重症监护的 COVID-19 患者的特征和结局:一项全国性队列研究。
CMAJ Open. 2021 Mar 8;9(1):E181-E188. doi: 10.9778/cmajo.20200250. Print 2021 Jan-Mar.
5
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
6
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.阿根廷 COVID-19 有创通气患者的临床特征和结局(SATICOVID):一项前瞻性、多中心队列研究。
Lancet Respir Med. 2021 Sep;9(9):989-998. doi: 10.1016/S2213-2600(21)00229-0. Epub 2021 Jul 2.
7
Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study.肥胖与 COVID-19 住院患者疾病严重程度的关联:一项回顾性队列研究。
Obes Res Clin Pract. 2021 Mar-Apr;15(2):172-176. doi: 10.1016/j.orcp.2021.02.006. Epub 2021 Feb 25.
8
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局:一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
9
Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.卡塔尔一项回顾性队列研究:COVID-19 患者的消化系统受累及临床结局。
World J Gastroenterol. 2021 Dec 14;27(46):7995-8009. doi: 10.3748/wjg.v27.i46.7995.
10
Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.2020年2月至8月第一波疫情期间瑞士住院的COVID-19患者出现严重后果的风险因素:前瞻性观察队列研究。
Swiss Med Wkly. 2021 Jul 28;151:w20547. doi: 10.4414/smw.2021.20547. eCollection 2021 Jul 19.

引用本文的文献

1
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry.用于治疗血液系统恶性肿瘤的新冠患者的奈玛特韦/利托那韦:来自EPICOVIDEHA注册研究的报告
EClinicalMedicine. 2023 Apr;58:101939. doi: 10.1016/j.eclinm.2023.101939. Epub 2023 Apr 6.

本文引用的文献

1
COVID-19 hospital admissions: Brazil's first and second waves compared.新型冠状病毒肺炎住院情况:巴西第一波和第二波疫情对比
Lancet Respir Med. 2021 Aug;9(8):e82-e83. doi: 10.1016/S2213-2600(21)00287-3. Epub 2021 Jul 15.
2
COVID-19 and Obesity: An Epidemiologic Analysis of the Brazilian Data.新型冠状病毒肺炎与肥胖症:巴西数据的流行病学分析
Int J Endocrinol. 2021 May 5;2021:6667135. doi: 10.1155/2021/6667135. eCollection 2021.
3
Discrepancies in the clinical and radiological profiles of COVID-19: A case-based discussion and review of literature.新型冠状病毒肺炎临床与影像学特征的差异:基于病例的讨论及文献综述
World J Radiol. 2021 Apr 28;13(4):75-93. doi: 10.4329/wjr.v13.i4.75.
4
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.新冠病毒谜题:解析新疾病实体的病理生理学和表型。
Lancet Respir Med. 2021 Jun;9(6):622-642. doi: 10.1016/S2213-2600(21)00218-6. Epub 2021 May 6.
5
Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review.肥胖作为 COVID-19 重症和并发症的风险因素:综述。
Cells. 2021 Apr 17;10(4):933. doi: 10.3390/cells10040933.
6
Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives.理解肥胖症和 COVID-19 的共同流行:当前证据、与以往流行的比较、机制以及预防和治疗观点。
Curr Obes Rep. 2021 Sep;10(3):214-243. doi: 10.1007/s13679-021-00436-y. Epub 2021 Apr 28.
7
Clinical characteristics of older patients with COVID-19: a systematic review of case reports.新型冠状病毒肺炎老年患者的临床特征:病例报告的系统评价
Dement Neuropsychol. 2021 Jan-Mar;15(1):1-15. doi: 10.1590/1980-57642021dn15-010001.
8
Non-invasive respiratory support strategies in COVID-19.2019冠状病毒病的无创呼吸支持策略
Lancet Respir Med. 2021 Jun;9(6):553-556. doi: 10.1016/S2213-2600(21)00168-5. Epub 2021 Apr 16.
9
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.巴西玛瑙斯市 P.1 型 SARS-CoV-2 谱系的基因组学和流行病学研究。
Science. 2021 May 21;372(6544):815-821. doi: 10.1126/science.abh2644. Epub 2021 Apr 14.
10
Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis.合并症对 COVID-19 重症和非重症患者的潜在影响:系统评价和荟萃分析。
Medicine (Baltimore). 2021 Mar 26;100(12):e24971. doi: 10.1097/MD.0000000000024971.